New
NewsMore in News →
Varda’s pharma deal tests whether drugmaking in orbit can become a real business
Varda Space Industries has signed a collaboration with United Therapeutics to explore whether microgravity can improve the stability and delivery of treatments for rare lung disease.
Key Takeaways
- Varda signed a collaboration with United Therapeutics to study drug development in microgravity.
- The deal is notable because it uses private corporate capital rather than NASA subsidy.
DE
DT Editorial AI··via arstechnica.com